BIOMAT Database Logo BIOMAT Database Logo

Cellular microRNA and the tumorigenesis of hepatocellular carcinoma. 2012

Yu Li, and Kris V Kowdley
Benaroya Research Institute and Center for Liver Disease, Digestive Disease Institute Virginia, Mason Medical Center, Seattle, Washington 98101, USA.

UI MeSH Term Description Entries

Related Publications

Yu Li, and Kris V Kowdley
MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.
January 2013, Gastroenterology research and practice,
Yu Li, and Kris V Kowdley
MicroRNA‑144 suppresses tumorigenesis of hepatocellular carcinoma by targeting AKT3.
February 2015, Molecular medicine reports,
Yu Li, and Kris V Kowdley
MicroRNA-1271 inhibits cellular proliferation of hepatocellular carcinoma.
December 2017, Oncology letters,
Yu Li, and Kris V Kowdley
MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.
January 2014, BioMed research international,
Yu Li, and Kris V Kowdley
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p.
January 2023, Journal of hepatocellular carcinoma,
Yu Li, and Kris V Kowdley
MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.
June 2017, Experimental and therapeutic medicine,
Yu Li, and Kris V Kowdley
Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766.
January 2020, OncoTargets and therapy,
Yu Li, and Kris V Kowdley
MicroRNA and hepatocellular carcinoma.
August 2009, Hepatology research : the official journal of the Japan Society of Hepatology,
Yu Li, and Kris V Kowdley
Impaired microRNA processing enhances cellular transformation and tumorigenesis.
May 2007, Nature genetics,
Yu Li, and Kris V Kowdley
MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2.
April 2016, Cancer science,
Copied contents to your clipboard!